Analgesia for major laparoscopic abdominal surgery using Intrathecal Morphine. A Feasibility Study.

Phase 4

Completed

• Conditions: Post operative pain; Quality of recovery; Anaesthesiology - Pain management

• Registration Number: ACTRN12619000355178
• Lead Sponsor: Dr Katrina Pirie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-03-06
• Study Completion: 2021-07-15
• Last Update Posted: 13 December 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 51

Inclusion Criteria

•> 18 years old
•Patients scheduled for elective major laparoscopic or lap-assisted abdominal surgery, and
•Planned operative time of over 2 hours

Exclusion Criteria

- < 18 years old
- Patient decline or inability to consent
- Contraindication to morphine
- Contraindication to a neuraxial injection including local site concerns, coagulopathy (including anticoagulant medication within safe timeframe), raised intracranial pressure, and untreated sepsis
- Cognitive impairment or language proficiency leading to inability to complete QoR-15 questionnaire or understand the pain scores
- Chronic pain, including baseline opioid use prior to hospital admission
- Women lactating or pregnant

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To measure the ability to recruit eligible patients into the study. Criteria: The study protocol will be assessed as feasible if a recruitment rate of at least 50% is achieved.<br>[12 months after recruitment commences];To measure the ability to successfully deliver each of the analgesic techniques according to the research protocol. Criteria: The study protocol will be assessed as feasible if a successful delivery rate, without need for cross-over, of at least 80% is achieved. Delivery rate data will be collected from hospital records. [1 day from recruitment of patient]